Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

<i>ASXL1</i> mutations accelerate bone marrow fibrosis via EGR1-TNFA axis-mediated neoplastic fibrocyte generation in myeloproliferative neoplasms
Zhongxun Shi, Jinqin Liu, Yingying Zhao, et al.
Haematologica (2022) Vol. 108, Iss. 5, pp. 1359-1373
Open Access | Times Cited: 15

Showing 15 citing articles:

The Role of Somatic Mutations in Ischemic Stroke: CHIP’s Impact on Vascular Health
Aiman Kinzhebay, Amankeldi A. Salybekov
Neurology International (2025) Vol. 17, Iss. 2, pp. 19-19
Open Access | Times Cited: 1
Association of Myelofibrosis Phenotypes with Clinical Manifestations, Molecular Profiles, and Treatments
Helen T. Chifotides, Srđan Verstovšek, Prithviraj Bose
Cancers (2023) Vol. 15, Iss. 13, pp. 3331-3331
Open Access | Times Cited: 14
Comprehensive biomarker profiles in hematological malignancies: improving diagnosis, prognosis, and treatment
Ali Golestan, Mohammadrasul Zareinejad, Amin Ramezani
Biomarkers in Medicine (2025), pp. 1-16
Closed Access
The Role of Signalling Pathways in Myocardial Fibrosis in Hypertrophic Cardiomyopathy
Patryk Skórka, Jakub Piotrowski, Estera Bakinowska, et al.
Reviews in Cardiovascular Medicine (2025) Vol. 26, Iss. 2
Open Access
Targeting CD38 effectively prevents myelofibrosis in myeloproliferative neoplasms
Yiru Yan, Jinqin Liu, Sophia Zhao, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
DNA Methylation in Ph-Negative Myeloproliferative Neoplasms: Prognostic Role and Therapeutic Implications
Paola Barone, Adele Bottaro, Rossana Leanza, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 4, pp. 227-227
Open Access
Potential application of the bulk RNA sequencing in routine MPN clinics
Shenglong Li, Sanyun Wu, Mingli Xu, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Non-driver mutations landscape in different stages of primary myelofibrosis determined ASXL1 mutations play a critical role in disease progression
Xin Yan, Zefeng Xu, Peihong Zhang, et al.
Blood Cancer Journal (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Targeting BIRC5 as a Therapeutic Approach to Overcome ASXL1-associated Decitabine Resistance
Ming Yao, Xiao Jiang, Fangnan Xiao, et al.
Cancer Letters (2024) Vol. 593, pp. 216949-216949
Closed Access | Times Cited: 1
Micheliolide exerts effects in myeloproliferative neoplasms through inhibiting STAT3/5 phosphorylation via covalent binding to STAT3/5 proteins
Huijun Huang, Jinqin Liu, Lin Yang, et al.
Blood Science (2023)
Open Access | Times Cited: 2
Inflammation and bone marrow fibrosis: novel immunotherapeutic targets
Francesca Rossella Calledda, Alessandro Malara, Alessandra Balduini
Current Opinion in Hematology (2023)
Closed Access | Times Cited: 2
TNF-α is a predictive marker in distinguishing myeloproliferative neoplasm and idiopathic erythrocytosis/thrombocytosis: development and validation of a non-invasive diagnostic model
Zhenhao Wang, Yu Mei, Zhuming Yang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Clonal hematopoiesis in LGI1‐antibody encephalitis
Soo Jean Shin, Yoonhyuk Jang, Soo Hyun Ahn, et al.
Annals of Clinical and Translational Neurology (2024) Vol. 11, Iss. 10, pp. 2785-2791
Open Access
Clonal evolution: a landmark of MPN evolution
Nabih Maslah, Stéphane Giraudier, Bruno Cassinat, et al.
Frontiers in Hematology (2024) Vol. 3
Open Access
Non-driver mutations landscape in different stages of primary myelofibrosis determined ASXL1 mutations play a critical role in disease progression
Xin Yan, Zefeng Xu, Peihong Zhang, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
“ASXL1”-erating inflammation and bone marrow fibrosis in myeloproliferative neoplasms
Hélène F.E. Gleitz, Rebekka K. Schneider
Haematologica (2022) Vol. 108, Iss. 5, pp. 1203-1204
Open Access | Times Cited: 1
Page 1

Scroll to top